The PIF (Product Information File) is one of the cornerstones of cosmetic regulatory compliance in the European Union. It is not just a simple administrative file kept somewhere in case an authority asks for it one day. It is the set of technical documentation that must demonstrate that a cosmetic product is safe, has been properly assessed, and complies with Regulation (EC) No 1223/2009.
When the PIF contains errors, inconsistencies or is not kept up to date, the issue is not merely documentary. From a regulatory perspective, those deficiencies may be interpreted as a sign that the product is not properly controlled. That increases the risk of observations, withdrawals or sanctions. Because yes, in European cosmetics, paperwork matters. Much more than some brands would like to admit.
The role of the cosmetic PIF in compliance with Regulation 1223/2009
According to Article 11 of Regulation (EC) No 1223/2009, the PIF must be available at the address of the Responsible Person and contain all the information necessary to demonstrate the conformity of the cosmetic product. It is not enough for it to simply exist. It must be complete, coherent, and capable of technically supporting the safety and legality of the product.
From a technical perspective, the PIF functions as a structure of scientific and regulatory evidence. It brings together the formulation, labelling, safety report, raw material data, stability studies, microbiological control, and all relevant information required to justify that the product may be marketed in the EU.
That is why, when the file is poorly prepared, the problem is rarely confined to a single page. It usually reveals a broader lack of consistency in the development, assessment, and maintenance of the product.
Consistency errors in the cosmetic PIF
One of the most common failings in a PIF is the lack of consistency between its different parts. The formulation, the Cosmetic Product Safety Report (CPSR), the labelling, and the CPNP notification must all match. If they do not, the file loses technical strength and regulatory credibility.
Some frequent inconsistencies include:
- differences in the declared ingredients;
- variations in concentrations between documents;
- formula changes not reflected in the CPSR;
- discrepancies between the final label and the content of the file;
- or CPNP notifications that do not match the actual version of the product.
These errors are not minor. Differences in ingredients or concentrations directly affect the toxicological assessment and may render the safety conclusion invalid. From the point of view of competent authority, these inconsistencies may be interpreted as a lack of control over the product and the documentary system supporting it.
Deficiencies in the cosmetic product safety report (CPSR)
The CPSR, defined in Annex I of the Regulation, is the scientific core of the PIF. Its quality determines the validity of the entire safety assessment. A file may appear complete at first glance, but if the CPSR is poorly substantiated, the product remains regulatorily exposed.
In practice, some of the most concerning deficiencies include:
- assessments based on incomplete data;
- lack of proper justification of the margin of safety (MoS);
- failure to consider real consumer exposure;
- omission of relevant impurities;
- use of outdated or insufficient toxicological data;
- and safety conclusions that are too generic or poorly developed.
A robust safety assessment cannot be limited to copying data from previous sources and assembling it without proper judgement. It must integrate up-to-date information, apply recognised toxicological principles, and scientifically justify each conclusion. In other words, the CPSR is not there to fill a gap in the file. It is there to support the entire file.
Insufficient information on raw materials
Another frequent problem is the lack of sufficient technical information on raw materials. In many files, there is an excessive reliance on safety data sheets (SDS) as the only documentary source. However, from a regulatory perspective, those sheets are usually not enough for a complete cosmetic assessment.
To properly assess product safety, the file should contain adequate information on aspects such as:
- raw material specifications;
- toxicological profile;
- relevant impurities and traces;
- information on regulatory restrictions;
- and any characteristic that is critical for safe use.
When this data is missing, the safety assessor works on an incomplete basis. And if the basis is incomplete, the conclusion is weakened as well.
Problems in stability studies
Product stability must be scientifically justified. It is not enough to assume that a formula “holds up well” because it has not caused obvious issues or because a similar one performed adequately in the past. A solid file requires studies that are properly designed and representative of the real or foreseeable conditions of storage and use.
Among the most common errors are:
- studies that are too limited or poorly designed;
- absence of clear acceptance criteria;
- lack of monitoring of relevant parameters;
- and data that does not reasonably support the shelf life or the PAO of the product.
When stability is not properly demonstrated, not only is product quality compromised. Safety, preservation efficacy, and the validity of the information provided to the consumer may also be affected.
Deficiencies in microbiological control
Microbiological control is especially important in products with an aqueous phase or products that are susceptible to contamination. However, it is still relatively common to find files with incomplete, insufficient, or poorly justified microbiological information.
The most relevant deficiencies at this point usually include:
- lack of adequate microbiological data;
- absence of a challenge test where it is necessary;
- unclear acceptance criteria;
- and weak justifications for the product’s preservation strategy.
These shortcomings represent a real risk. A microbiologically poorly controlled product may compromise consumer safety and lead to significant non-compliance during an inspection.
Failure to keep the PIF updated
One of the most serious and, at the same time, most common mistakes is treating the PIF as a closed file that is prepared once and then left untouched for years. The problem is that the PIF must be kept updated throughout the entire life cycle of the product.
That means any relevant change must be reflected in the file, for example:
- formulation changes;
- new toxicological information;
- changes in the supplier or raw material specifications;
- labelling updates;
- applicable regulatory changes;
- or new evidence related to safety or efficacy.
An outdated PIF may invalidate the safety assessment and turn an apparently compliant product into a regulatorily vulnerable one.
How to reduce the risk of sanctions
Avoiding errors in the PIF does not depend solely on having documentation, but on implementing a realistic review and maintenance methodology. To reduce the risk of regulatory non-compliance, it is advisable to work with a strategy that includes:
- consistency between all documents in the file;
- rigorous technical review of the CPSR;
- complete collection of raw material information;
- well-justified stability and microbiological studies;
- documentary change control;
- and periodic updating of the PIF.
Companies that integrate these principles into their processes not only reduce the risk of sanctions. They also improve their ability to respond to audits, inspections, and regulatory reviews.
How SHAPYPRO can help
SHAPYPRO can help manufacturers and brands review their PIF to detect documentary inconsistencies, deficiencies in the CPSR, gaps in raw material information, and weaknesses in stability or microbiology. This technical review helps strengthen regulatory compliance, reduce the risk of sanctions, and keep the file aligned with the evolution of the product and the applicable regulations.
Conclusion
The Product Information File (PIF) is a critical element of compliance with Regulation 1223/2009. Its proper preparation requires scientific rigour, documentary consistency, and continuous updating. When the file contains errors in the formulation, the CPSR, raw materials, stability, microbiology, or documentary maintenance, regulatory risk increases directly.
A well-built PIF not only helps avoid sanctions. It also demonstrates that the product has been developed and assessed with the level of control required by the European market. And in regulated cosmetics, that is not an extra. It is the minimum needed to avoid discovering the weaknesses only when the competent authority is already reading them.